Teva: long acting olanzapine TEV’749 or Zyprexa shows success in schizophrenia
TEV’749 achieved reductions in schizophrenia symptoms, as measured by differences in the Positive and Negative Syndrome Scale (PANSS) scores, from ...
TEV’749 achieved reductions in schizophrenia symptoms, as measured by differences in the Positive and Negative Syndrome Scale (PANSS) scores, from ...
1. Low dose Olanzapine (2.5 mg) demonstrated similar anti-emetic effect to standard dose olanzapine in patients receiving emetogenic chemotherapy 2. ...
1. There was no evidence of superiority among the different antipsychotics. 2. Choice of antipsychotic regimen for schizophrenia maintenance should ...
1. In this randomized controlled trial, patients with Major depressive disorder with psychotic features who were stable on olanzapine and ...
1. In this randomized controlled trial, patients with Major depressive disorder with psychotic features who were stable on olanzapine and ...
Rituximab maintenance for a maximum of 5 years after single-agent Rituximab induction in follicular lymphoma: Results of the randomized ...
1. Atypical antipsychotics given to elderly patients in outpatient setting were associated with a 75% increased 90-day risk of hospitalization ...
1. Approximately 74% of schizophrenic patients discontinued their medications before 18 months, with the median being 6 months. 2. Olanzapine ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.